| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |